Docetaxel chemotherapy for metastatic hormone refractory prostate cancer as first-line palliative chemotherapy and subsequent re-treatment: Birmingham experience.

J Ansari, Syed Hussain, A Zarkar, JS Tanguay, J Bliss, John Glaholm

Research output: Contribution to journalArticle

41 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Docetaxel chemotherapy for metastatic hormone refractory prostate cancer as first-line palliative chemotherapy and subsequent re-treatment: Birmingham experience.'. Together they form a unique fingerprint.

Medicine & Life Sciences